We narrowed to 3,702 results for: WOL

#161173

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161081

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161342

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Sept. 15, 2021

Industry, Academic Institutions, and Nonprofits

#199261

Optimized single AAV vector for expressing N-terminal fusion Nme2Cas9-ABE8e and one U6 driven sgRNA targeting mouse Rosa26 gene. This optimized construct showed improved in vivo editing efficiency.

Erik Sontheimer

Zhang et al GEN Biotechnol. 2022 Jun 1;1(3):285-299.

April 10, 2023

Academic Institutions and Nonprofits only

#161065

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161194

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161104

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161452

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Sept. 15, 2021

Industry, Academic Institutions, and Nonprofits

#161407

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Sept. 15, 2021

Industry, Academic Institutions, and Nonprofits

#161295

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Sept. 15, 2021

Industry, Academic Institutions, and Nonprofits